138 related articles for article (PubMed ID: 12095990)
21. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
González-Yanes C; Sánchez-Margalet V
Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
[TBL] [Abstract][Full Text] [Related]
22. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase.
Welsh GI; Foulstone EJ; Young SW; Tavaré JM; Proud CG
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):15-20. PubMed ID: 7945234
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase regulation in hyperinsulinemic/obese progeny of rats fed a high carbohydrate formula in their infancy.
Srinivasan M; Vadlamudi S; Patel MS
Int J Obes Relat Metab Disord; 1996 Nov; 20(11):981-9. PubMed ID: 8923154
[TBL] [Abstract][Full Text] [Related]
24. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
[TBL] [Abstract][Full Text] [Related]
25. Regulation of glycogen synthase in rat hepatocytes. Evidence for multiple signaling pathways.
Lavoie L; Band CJ; Kong M; Bergeron JJ; Posner BI
J Biol Chem; 1999 Oct; 274(40):28279-85. PubMed ID: 10497184
[TBL] [Abstract][Full Text] [Related]
26. Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3.
Choi WS; Sung CK
Biochim Biophys Acta; 2000 Jul; 1475(3):225-30. PubMed ID: 10913820
[TBL] [Abstract][Full Text] [Related]
27. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism.
Summers SA; Kao AW; Kohn AD; Backus GS; Roth RA; Pessin JE; Birnbaum MJ
J Biol Chem; 1999 Jun; 274(25):17934-40. PubMed ID: 10364240
[TBL] [Abstract][Full Text] [Related]
28. Activation of protein phosphatase-1 isoforms and glycogen synthase kinase-3 beta in muscle from mdx mice.
Villa-Moruzzi E; Puntoni F; Marin O
Int J Biochem Cell Biol; 1996 Jan; 28(1):13-22. PubMed ID: 8624841
[TBL] [Abstract][Full Text] [Related]
29. The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity.
Singh LP; Crook ED
J Investig Med; 2000 Jul; 48(4):251-8. PubMed ID: 10916283
[TBL] [Abstract][Full Text] [Related]
30. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis.
Hurel SJ; Rochford JJ; Borthwick AC; Wells AM; Vandenheede JR; Turnbull DM; Yeaman SJ
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):871-7. PubMed ID: 9003374
[TBL] [Abstract][Full Text] [Related]
31. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
Sale EM; Hodgkinson CP; Jones NP; Sale GJ
Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.
Samuel VT; Liu ZX; Qu X; Elder BD; Bilz S; Befroy D; Romanelli AJ; Shulman GI
J Biol Chem; 2004 Jul; 279(31):32345-53. PubMed ID: 15166226
[TBL] [Abstract][Full Text] [Related]
33. Characterization of GSK-M, a glycogen synthase kinase from rat skeletal muscle.
Hegazy MG; Thysseril TJ; Schlender KK; Reimann EM
Arch Biochem Biophys; 1987 Nov; 258(2):470-81. PubMed ID: 2823716
[TBL] [Abstract][Full Text] [Related]
34. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
[TBL] [Abstract][Full Text] [Related]
35. Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats.
Semiz S; Orvig C; McNeill JH
Mol Cell Biochem; 2002 Feb; 231(1-2):23-35. PubMed ID: 11952162
[TBL] [Abstract][Full Text] [Related]
36. In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats.
Bhanot S; Salh BS; Verma S; McNeill JH; Pelech SL
Am J Physiol; 1999 Aug; 277(2 Pt 1):E299-307. PubMed ID: 10444426
[TBL] [Abstract][Full Text] [Related]
37. RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.
Standaert ML; Bandyopadhyay G; Antwi EK; Farese RV
Endocrinology; 1999 May; 140(5):2145-51. PubMed ID: 10218965
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition by hGRB10zeta of insulin-induced glycogen synthase activation: evidence for a novel signaling pathway.
Mounier C; Lavoie L; Dumas V; Mohammad-Ali K; Wu J; Nantel A; Bergeron JJ; Thomas DY; Posner BI
Mol Cell Endocrinol; 2001 Feb; 173(1-2):15-27. PubMed ID: 11223174
[TBL] [Abstract][Full Text] [Related]
39. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC
Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
